BOLD vs CNC · P/E 0.1, $24.6M cap vs P/E 8.4, rev $163.07B
Boundless Bio, Inc. Common Stock (BOLD) versus Centene Corp (CNC) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
Centene Corp (CNC) is a healthcare plans company listed on US.
BOLD does not have a complete income-statement cache yet.
Latest reported CNC revenue for 2024-12-31 was $163.07B. Net income was $3.29B. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Not investment advice. Open the BOLD and CNC stock pages for the full models.
Not investment advice.